CTRI/2025/08/092754Not yet recruitingPhase 2/3
Randomised controlled clinical trial to evaluate the efficacy of Pippalyadi yoga in Kaphaja kasa in children.
Dr Rudresh Bhujaji Gawali1 site in 1 country70 target enrollmentStarted: August 20, 2025Last updated:
Trial Snapshot
- Phase
- Phase 2/3
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 70
- Locations
- 1
- Primary Endpoint
- The primary outcome focuses on the clinical efficacy of pippalyadi yoga in managing kaphaja kasa in children. It will be assessed based on symptomatic relief (frequency of bouts of cough, Nasal discharge, aruchi and Sputum) and objective parameter.
Study Overview
Brief Summary
Cough is the 5th common for which patients seek care and prevalence rate of which is 25% in children worldwide. The traditional Indian medicine gives specific line of treatment and various remedies on kaphaja Kasa (productive cough) as prescribed in text. That’s why this subject for study has been chosen.
Study Design
- Study Type
- Interventional
- Allocation
- Coin toss, Lottery, toss of dice, shuffling cards etc
- Masking
- None
Eligibility Criteria
- Ages
- 8.00 Year(s) to 12.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •1.Productive cough associated with or without other symptoms described in the context of Kaphaja Kasa will be included. 2.Kaphajkasa less than 15 days duration will be selected. 3.Patients will be selected irrespective of sex, Caste between the age group of 8.
Exclusion Criteria
- •1.All types of kasa except kaphajkasa.
- •2.Kasa as an anubandhalakshana in already diagnosed patients like Pneumonia, Emphysema, Asthma.
- •3.Age less than 8yrs and more than 12yrs.
Outcomes
Primary Outcomes
The primary outcome focuses on the clinical efficacy of pippalyadi yoga in managing kaphaja kasa in children. It will be assessed based on symptomatic relief (frequency of bouts of cough, Nasal discharge, aruchi and Sputum) and objective parameter.
Time Frame: 10 days treatment with 3 follow ups on 4th, 7th and 10 th day.
Secondary Outcomes
- Pippalyadi churna is more effective than sitopaladi churna(Initial Assessment at 0 day)
Investigators
Dr. Rudresh Bhujaji Gawali
late ledari redekar ayurvedic mahavidyala,Gadhinglaj,Kolhapur
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Phase 2
A study to test whether BI 1839100 improves cough in people with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis2023-510249-79-00Boehringer Ingelheim International GmbH, Boehringer Ingelheim Espana S.A.100
Not yet recruiting
Not Applicable
COMPARATIVE CLINICAL STUDY TO REDUCE THE SYMPTOMS OF TAMAKA SHWASA IN CHILDREN WITH BHARANGI GUDA AND DRAKSHADI LEHA.CTRI/2026/02/105065Dr. Baishali Dani40
Recruiting
Phase 4
Trial of an AI-enabled Digital Stethoscope to Improve Antibiotic StewardshipNCT07362433Johns Hopkins University2,500
Recruiting
Phase 2
A multicenter, randomized, blinded, placebo controlled, phase II study to evaluate the safety and efficacy of cell therapy based with artificially expanded CD4+CD25+CD127- regulatory lymphocytes and anti-CD20 antibody in pediatric patients with presymptomatic diabetes type 1 (stage 1)2023-505226-33-00Poltreg S.A.150
Unknown
Phase 4
Bromelin, a Compound Prepared With Ananas Comocus Extract and Honey, for Acute CoughCough, AcuteNCT01356693Universidade Federal de Pernambuco102